epibatidine has been researched along with abt 594 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, DJ; Arneric, SP; Bannon, AW; Briggs, CA; Buckley, MJ; Campbell, JE; Decker, MW; Donnelly-Roberts, DL; He, Y; Holladay, MW; Kim, DJ; Kuntzweiler, TA; Lin, NH; Piattoni-Kaplan, M; Ryther, KB; Wasicak, JT; Williams, M | 1 |
Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Liljefors, T | 1 |
Anderson, DJ; Bunnelle, WH; Hutchins, CW; Schrimpf, MR; Sippy, KB | 1 |
1 review(s) available for epibatidine and abt 594
Article | Year |
---|---|
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Humans; Ligands; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Nicotinic Antagonists; Protein Conformation; Protein Subunits; Receptors, Nicotinic | 2005 |
2 other study(ies) available for epibatidine and abt 594
Article | Year |
---|---|
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Diastole; Female; Humans; Injections, Intraperitoneal; Kinetics; Mice; Molecular Structure; Muscle Contraction; Neuroblastoma; Neurons; Nicotinic Agonists; Oocytes; Pain; Pain Measurement; Pyridines; Rats; Receptors, Nicotinic; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Xenopus | 1998 |
Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
Topics: Animals; Azetidines; Chemistry, Pharmaceutical; Diamines; Drug Design; Humans; Kinetics; Ligands; Models, Chemical; Molecular Conformation; Pyridines; Rats; Receptors, Nicotinic; Structure-Activity Relationship | 2009 |